As of November 2024 Regeneron Pharmaceuticals has a market cap of £65.80 Billion. This makes Regeneron Pharmaceuticals the world's 215th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
On Nov 14th, 2024 the market cap of Regeneron Pharmaceuticals was reported to be: